Forte Biosciences (FBRX) Change in Accured Expenses (2016 - 2026)
Forte Biosciences (FBRX) posted Change in Accured Expenses of -$4.29 million for Q2 2026, compared with -$181,000 a year earlier.
Powered by 
Analysis
Forte Biosciences (FBRX) Change in Accured Expenses (2016 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Forte Biosciences was $2.41 million; for FY2025, it was $8.4 million.
- In prior years, Forte Biosciences' Change in Accured Expenses was $109,000 in FY2024 (-41.4%), $186,000 in FY2023 (-84.7%), $1.21 million in FY2022 and -$207,000 in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Change in Accured Expenses in data going back to Q1 2016.
- According to Business Quant data, Change in Accured Expenses for the three prior quarters was -$198,000 (Q1 2026), $3.26 million (Q4 2025) and $3.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Forte Biosciences | 1.58 Bn | 1.38 Bn | - | -4.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.29 Mn |
| Mar 31, 2026 | -198,000.00 |
| Dec 31, 2025 | 3.26 Mn |
| Sep 30, 2025 | 3.63 Mn |
| Jun 30, 2025 | -181,000.00 |
| Mar 31, 2025 | 1.69 Mn |
| Dec 31, 2024 | -1.07 Mn |
| Sep 30, 2024 | -422,000.00 |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | -595,000.00 |
| Dec 31, 2023 | 125,000.00 |
| Sep 30, 2023 | -1.18 Mn |
| Jun 30, 2023 | 846,000.00 |
| Mar 31, 2023 | 392,000.00 |
| Dec 31, 2022 | 924,000.00 |
| Sep 30, 2022 | 287,000.00 |
| Jun 30, 2022 | 135,000.00 |
| Mar 31, 2022 | -132,000.00 |
| Dec 31, 2021 | -598,000.00 |
| Sep 30, 2021 | -583,000.00 |
API Access
Forte Biosciences Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=FBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "FBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=FBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();